Onivyde Ipsen:Onivyde® regimen demonstrated statistically significant ...

Onivyde® regimen demonstrated statistically significant ...

Onivyde® regimen demonstrated statistically significant ...

2022年11月9日—IpsenhasexclusivecommercializationrightsforthecurrentandpotentialfutureindicationsforOnivydeintheU.S.Servier,anindependent ...。其他文章還包含有:「Correction」、「IpsenannouncesU.S.FDAsubmissionacceptanceofits...」、「IpsenpresentsPhaseIIINAPOLI3trialofOnivyde...」、「IpsenpresentsPhaseIIINAPOLI3trialofOnivyde®...」、「Onivyde®(irinotecanliposomeinjection)」、「ONIVYDE®(irinotec...

查看更多 離開網站